ReviewJournal of hematology & oncology2026

Cell-cycle targeted cancer therapy: clinical advances, biological gaps, and the emergence of selective CDK4 inhibitors.

Ava Safaroghli-Azar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.